This CME and CNE-accredited activity reviews the basic science behind the development of inhibitor antibodies to treatment for hemophilia, and more.
A new patient financial assistance program has become available for individuals with hemophilia.
HANDI, NHF’s information resource center, highlights resources aimed for new college students.
NHF submitted a letter on the "American Patients First" drug pricing blueprint.
The HTRS MRA provides financial support for qualified fellows or junior attending/junior faculty pursuing clinical, translational, or basic science research in hemostasis and/or thrombosis under the guidance of an experienced mentor.
Emory HTC researchers uncovered some noteworthy findings in this unique study on clinic non-attendance rates, including a small at-risk subgroup that may warrant further investigations.
The first stage will collect data that will be eventually used to evaluate the efficacy and safety of the investigational hemophilia B therapy.
Take part in a survey to shape VWD Guidelines. We want to hear from people with VWD, people who care for those with VWD, or clinicians and other healthcare professionals who treat people with VWD.
This My Life, Our Future (MLOF) update highlights the projects’ potential for driving scientific and clinical breakthroughs through genotyping analysis.
Medscape has launched the latest educational activity in their “Clinical Advances in Gene Therapy for Hemophilia” series, which is presented through a collaboration between Medscape, NHF, the European Haemophilia Consortium and WFH.